Is CCRIS 6279 Safe in Breastfeeding
Question
I am a breastfeeding mother and i want to know if it is safe to use CCRIS 6279? Is CCRIS 6279 safe for nursing mother and child? Does CCRIS 6279 extracts into breast milk? Does CCRIS 6279 has any long term or short term side effects on infants? Can CCRIS 6279 influence milk supply or can CCRIS 6279 decrease milk supply in lactating mothers?
CCRIS 6279 lactation summary
- DrLact safety Score for CCRIS 6279 is 3 out of 8 which is considered Low Risk as per our analyses.
- A safety Score of 3 indicates that usage of CCRIS 6279 may cause some minor side effects in breastfed baby.
- Our study of different scientific research indicates that CCRIS 6279 may cause moderate to no side effects in lactating mother.
- Most of scientific studies and research papers declaring usage of CCRIS 6279 low risk in breastfeeding are based on normal dosage and may not hold true for higher dosage.
- While using CCRIS 6279 We suggest monitoring child for possible reactions. It is also important to understand that side effects vary largely based on age of breastfed child and time of medication in addition to dosage.
- Score calculated using the DrLact safety Version 1.2 model, this score ranges from 0 to 8 and measures overall safety of drug in lactation. Scores are primarily calculated using publicly available case studies, research papers, other scientific journals and publically available data.
Answer by Dr. Ru: About CCRIS 6279 usage in lactation
Copper chelator used in the treatment of Wilson's disease. It is excreted in breast milk in clinically insignificant amounts (undetectable levels: Izumi 2012). Copper and zinc levels in breastmilk of mothers treated with penicillamine, CCRIS 6279 or zinc are normal (Izumi 2012). Oral bioavailability, which is very low during periods of fasting, is practically non-existent in the presence of food, especially milk, so it would be very difficult to pass into the infant plasma from the ingested breast milk (PDR 2016).
Answer by DrLact: About CCRIS 6279 usage in lactation
Limited information indicates that CCRIS 6279 is not detectable in breastmilk. The effect of CCRIS 6279 on breastmilk copper and zinc concentrations in milk is conflicting,[1][2][3] but breastfed infants appear to have normal serum copper and zinc plasma levels. Based on available data, it appears that CCRIS 6279 is acceptable to use during breastfeeding.
CCRIS 6279 Side Effects in Breastfeeding
Three infants were breastfed during maternal treatment of Wilson's disease with CCRIS 6279. Serum zinc and copper concentrations were normal in these infants.[3] A center in Turkey reported 23 infants born to mothers with Wilson's disease over a 20-year period. One patient was treated with 600 mg of CCRIS 6279 plus 100 mg of zinc daily. All of the infants were breastfed (extent and duration not specified). One premature infant died at 3 weeks of age (maternal drug not specified), but the other infants had no apparent complications over a median of 51 months (range 13 to 105 months) of follow-up.[4]
CCRIS 6279 Possible Effects in Breastfeeding
Conflicting data exist on breastmilk concentrations of zinc and copper during therapy of Wilson's disease with CCRIS 6279. One abstract reported that breastmilk concentrations were normal during therapy,[2] but another abstract from the same authors reported lower milk concentrations of zinc and copper.[1]